(Page 2 of 2)
Bill Gates, to nuclear physics, to how his “invention company” fits in with venture capital and private equity.
This was a shocking and sad loss for the Seattle community. Grinstein was a founding partner in Second Avenue Partners, chairman of Coinstar, director of F5 Networks, and director of Labor Ready.
This story laid out the controversial saga of Dendreon’s prostate cancer drug, Provenge, while the company and its investors were awaiting key clinical trial results.
This piece was based on a riveting talk by Nick Hanauer of Second Avenue Partners. Hanauer, an early investor in Amazon and a number of other successes, spoke about what “breakthrough ideas” are, how to find them, and which companies are developing them.
This story tapped into the public’s fascination with newfangled aircraft and unorthodox methods of flight. Boeing’s project to develop an airship-helicopter hybrid, together with SkyHook, faces some technical challenges, as we laid out here. (Think maybe we should do more Boeing stories, or weird-vehicle stories?)
And here are 10 more “editors’ picks”—stories that we particularly liked, because they were fun, unique, and/or surprising, but which didn’t rank in our top 10 in terms of traffic: